Dialyze Direct Partners with CommuniCare Health to Provide On-Site Dialysis

Dialyze Direct | July 28, 2022 | Read time : 45:49 min

Dialyze Direct

Dialyze Direct, the nation’s leading provider of home hemodialysis services in Skilled Nursing Facilities. announced it has partnered with CommuniCare Family of Companies, one of the nation’s largest post-acute care providers, to conduct onsite hemodialysis services at its facilities around the U.S.

Founded in 1984 on the philosophy of “Serving with Pride,” CommuniCare’s standard of excellence, which focuses on patient care and quality of life, mirrors Dialyze Direct’s mission to change the dialysis industry by pioneering customized, gentler care proven to positively impact patients’ prognoses and quality of life. Dialyze Direct’s continued growth with like-minded healthcare providers has further solidified the company’s position as the foremost home hemodialysis provider to SNFs in the United States.

The ultimate goal of healthcare is to provide services that benefit our clients but also to ensure those services save or significantly prolong lives. As a result, we approach partnerships with the understanding that both parties share a common patient-first philosophy. We are pleased to bring our onsite dialysis offerings to CommuniCare’s facilities and join forces with a fellow provider that also views patient comfort and care as the cornerstone of their business model.”

Dialyze Direct’s Chairman and Co-Founder Henry Kauftheil

Dialyze Direct recently announced its acquisition of Chicago-based RenPro Renal Services, which provided dialysis services to patients in SNFs in Illinois, Indiana, Ohio and Kentucky. Earlier this year, the company completed its acquisition of Compass Home Dialysis, a regional SNF dialysis provider in Pennsylvania, and at the end of 2021, the company acquired Renew Dialysis, a regional SNF dialysis provider in Ohio and Virginia.

“Providing our residents with a better quality of life is what we strive for at CommuniCare,” said Ronald Wilheim, President of CommuniCare. “We are proud to partner with Dialyze Direct and that through this partnership we have another opportunity to raise the bar and innovate our level of care.”

Dialyze Direct now offers onsite dialysis services in more than 170 SNFs in Florida, Illinois, Indiana, Kentucky, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, Texas, Virginia, and West Virginia.

About Dialyze Direct
Founded in 2015, Dialyze Direct is a leading kidney care innovation company that seeks breakthrough solutions for patients suffering from kidney disease. With a mission to build the next generation of kidney care, Dialyze Direct leverages its leading nephrology specialists to develop new methods and technology to evolve the treatment options nephrologists have at their disposal. Dialyze Direct pioneered significant changes to the existing treatment model for dialysis patients in skilled nursing facilities (SNFs), in which many of the most medically challenging subsets of dialysis patients reside, and has grown to become the nation’s largest provider of home dialysis in the SNF setting. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols designed to tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors. Dialyze Direct currently operates in 13 states with new operations launching soon in additional states.

About CommuniCare Health Services
CommuniCare Health Services was founded in 1984 and is headquartered in Cincinnati, Ohio. The company currently operates more than 110 healthcare and rehabilitation centers in seven states.

Our centers focus on patient-centered care plans and provide specialized programing in cardiac, pulmonology, memory care & dementia, amputee and behavioral health. Our expert physicians and nurses provide care for the most medically complex residents. 


The future of Molecular Imaging is personal. Every step of the care you provide is an opportunity to make personalized decisions for your patients. One pathway focused on enabling intelligently efficient and precise, personalized care is Theranostics, the process of bringing together diagnostics and therapeutics.


The future of Molecular Imaging is personal. Every step of the care you provide is an opportunity to make personalized decisions for your patients. One pathway focused on enabling intelligently efficient and precise, personalized care is Theranostics, the process of bringing together diagnostics and therapeutics.

Related News


WELL Health Launches WELL AI Voice: The Ultimate Ambient AI Scribe to Give Physicians Their Time Back

PRnewswire | May 11, 2023

WELL Health Technologies Corp. a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce the launch of its ground-breaking product, WELL AI Voice. WELL AI Voice is a powerful and transformative product that reduces a provider's documentation and administrative burden by privately and securely capturing a patient encounter conversation and automatically generating a succinct and medically relevant chart note. The ambient scribe feature leverages cutting-edge generative AI capabilities, allowing providers to deliver improved care to their patients by focusing entirely on the patient, reducing provider burnout, and giving the provider more accurate documentation. WELL AI Voice is integrated directly into OSCAR Pro, works with WELL's Profile and Cerebrum EMRs and alongside any other EMR, and will be available as part of the ecosystem. Test results have demonstrated that physicians are experiencing a timesaving of up to 30% when using WELL AI Voice. Physicians have also commended the ability to maintain eye contact during patient visits as the ambient scribe no longer requires them to look at their computer to take notes. "The feedback from our physicians using WELL AI Voice has been overwhelmingly positive. It is incredible the amount of time being saved on documentation which has now been automated, allowing providers to focus their attention entirely on the patient, which patients love as well", said Michael Frankel, WELL's Chief Medical Officer. As part of its ongoing commitment to developing innovative solutions for healthcare providers, the Company has also launched, a program that encompasses the various AI capabilities that it will be building into its Provider Solutions platform offerings. This includes the investments WELL will be making as part of The WELL AI Investment Program, previously announced on April 25th, 2023, as well as other greenfield initiatives. WELL AI Voice is the first-generation product to be released as part of the program. "Today marks a major milestone for WELL as we launch WELL AI Voice," said Amir Javidan, COO of WELL Health Technologies. "With ambient scribe, we are tech-enabling providers with the power of AI and saving precious time by automating one of the most challenging and mundane parts of their daily work - documentation. The program is the foundation from which we will leverage the latest advancements in AI to empower providers and augment their practices. WELL AI Voice is the first of many AI capabilities we plan to introduce as part of our program." WELL AI Voice will on display at Booth 325 during the Pri-Med Canada In-Person Conference & Trade Show, which is being held at the International Centre in Toronto, ON. WELL representatives will be in attendance to provide live demonstrations throughout the conference. About WELL Health Technologies Corp. WELL is a practitioner-focused digital healthcare company. WELL's overarching mission is to positively impact health outcomes by leveraging technology to empower healthcare practitioners and their patients globally. WELL exists to enable healthcare practitioners with best-in-class technology and services. WELL has built the most comprehensive end-to-end healthcare system across Canada including the nation's largest network of clinics supporting primary care, specialized care, and diagnostics services. In the United States, WELL provides omni-channel healthcare services and solutions targeting specialized markets such as the gastrointestinal market, women's health, primary care, and mental disorders. In addition to providing patient services, WELL develops, integrates, and sells its own suite of technology software and solutions to medical clinics and healthcare practitioners. WELL's practitioner enablement platform includes: Electronic Medical Records ("EMR"), telehealth platforms, practice management, billing, Revenue Cycle Management digital health apps and data protection solutions.

Read More


WellSky® Introduces Enhanced Intelligence to the Discharge Process in CarePort Suite of Solutions to Facilitate Superior Care Transitions

Businesswire | April 21, 2023

WellSky, a leading health and community care technology company, today announced expanded capabilities in its CarePort suite of care transition solutions. These new enhancements equip discharge planners, care managers, and care coordinators with enhanced intelligence at the point of discharge to help them make more informed decisions and ensure patients receive the best possible care and support as they transition from the hospital to home or another care setting. WellSky and CarePort recently expanded its network with the acquisition of Curaspan. Curaspan clients using CarePort Discharge can now take advantage of an expanded solution set. “We're thrilled to offer our clients, including those in our newly expanded network available through Curaspan, capabilities to better engage patients and families and enhance their care planning and decision making throughout the discharge process,” said Dr. Lissy Hu, president of connected networks at WellSky. “Through these enhancements, WellSky is enabling care providers to deliver the right care, at the right time, in the right setting to achieve better health outcomes.” By extending CarePort Connect into the care transitions solutions, providers gain seamless access directly from their discharge planning workflows. This access delivers a deeper knowledge of past post-acute care utilization which is critical to help providers determine the appropriate level of care needed post-discharge and create a care plan tailored to the patient's specific needs. Accessing clinical data and encounter history at a patient’s most vulnerable point of transition can help reduce hospital readmissions and connect patients to the most appropriate care. CarePort Guide, available in CarePort Discharge, gives hospitals and health systems access to a more robust patient choice tool to assist patients and families in selecting high-quality post-acute care. CarePort Guide provides access to proprietary post-acute quality scores, highlights high-performing post-acute networks and collaboratives, and offers more robust agency profiles and guides, all sharable via text and email. By increasing patient satisfaction with the discharge process and reducing discharge delays, CarePort Guide brings a superior post-acute care selection tool to the market and can increase the number of patients attending in-network skilled nursing facilities by 7%. About WellSky® WellSky is one of America’s largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care. Our proven software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations scale processes, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to build healthy, thriving communities.

Read More


Laborie Launches alpHaONE, an Innovative GERD Diagnostic System

prnewswire | April 04, 2023

Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. announced the launch of the alpHaONE system that is specifically designed to diagnose gastroesophageal reflux disease and offers up to 96 hours of monitoring data. GERD is a chronic medical condition caused by the flow of contents from the stomach upwards into the esophagus resulting in both symptoms and complications. It is estimated that 20% of the US population suffers from GERD with the most common symptoms being heartburn and regurgitation1. With an increasing number of options for GERD diagnosis, patients and healthcare providers face a challenge in choosing the best solution for a clear diagnosis. alpHaONE offers a unique solution with its ergonomic and compact design, enlarged and easy-to-press buttons, and fail-safe capsule delivery system that protects the patient's esophagus. "alpHaONE is a patient-centric system that allows for comfortable monitoring and accurate, reliable data, fulfilling the needs of both patients and healthcare providers to diagnosis GERD," said Rhett Klein, Vice President of Sales and Marketing for Laborie's GI Business Unit. "Our primary objective has always been to provide solutions that elevate patient outcomes and enhance their overall experience and we look forward to launching this product." The comprehensive software application incorporated in the alpHaONE system consists of a Virtual Instruction Program, which allows for effortless navigation. In addition, user-customizable symptom buttons and automatic pH data analysis ensure a seamless user experience. Laborie will showcase alpHaONE at the Digestive Disease Week (DDW) event in Chicago, Illinois on May 6-9, 2023. About Laborie Medical Technologies Laborie is a global medical technology company focused on Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology & Neonatal Health headquartered in Portsmouth, New Hampshire. We manufacture and deliver high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity. Clinicians and hospitals look to us as the market-leading experts in our business segments, and we support our products with a world-class Clinical Education & Information program.

Read More